ProShare Advisors LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 111 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$43,000
-46.2%
14,375
-19.1%
0.00%
Q4 2021$80,0000.0%17,758
+7.5%
0.00%
Q3 2021$80,000
-42.4%
16,524
-18.6%
0.00%
Q2 2021$139,000
+9.4%
20,308
+13.0%
0.00%
Q1 2021$127,000
+21.0%
17,971
+7.6%
0.00%
Q4 2020$105,000
+94.4%
16,707
+34.1%
0.00%
Q3 2019$54,000
+5.9%
12,454
-3.2%
0.00%
Q2 2019$51,000
-33.8%
12,870
-10.7%
0.00%
Q1 2019$77,000
+5.5%
14,417
+1.4%
0.00%
-100.0%
Q4 2018$73,000
-55.2%
14,212
-15.4%
0.00%0.0%
Q3 2018$163,000
-8.4%
16,791
-3.6%
0.00%0.0%
Q2 2018$178,000
-23.3%
17,424
-2.4%
0.00%
-50.0%
Q1 2018$232,000
-30.3%
17,857
-3.9%
0.00%0.0%
Q4 2017$333,000
-23.3%
18,589
+7.6%
0.00%
-50.0%
Q3 2017$434,000
+11.3%
17,274
+6.7%
0.00%0.0%
Q2 2017$390,000
+42.9%
16,191
+14.1%
0.00%
+33.3%
Q1 2017$273,000
-1.1%
14,186
-20.7%
0.00%0.0%
Q4 2016$276,00017,8910.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders